Suppr超能文献

[泽口小组采用厚生省方案治疗晚期神经母细胞瘤]

[Therapy of advanced neuroblastoma by the protocol of the Welfare Ministry used by the Sawaguchi Group].

作者信息

Shida S, Arioka H, Hatayama Y, Nakadate H, Hatae Y, Takeda T

机构信息

Dept. of Pediatrics, National Sapporo Hospital.

出版信息

Gan To Kagaku Ryoho. 1988 Mar;15(3):425-9.

PMID:3348628
Abstract

Five patients with advanced neuroblastoma were treated with the protocol of the Welfare Ministry used by the Sawaguchi group. This protocol consists of cyclophosphamide (CPM), vincristine (VCR), 4'-O-tetrahydropyranyladriamycin (THP-ADM) and cisplatinum (CDDP). Two patients treated with this protocol as the first therapy obtained partial remission. Two patients who had obtained complete remission before the treatment with this protocol remained in complete remission after the treatment. One patient who had shown poor response to the therapy given before treatment with this protocol also showed poor response to the protocol. The most significant side effect with this protocol was myelosuppression, the severity of which was closely related to the dose of THP-ADM. Damage to the liver, kidney and heart was not very significant. We advocate that patients with advanced neuroblastoma can obtain complete remission with the aid of surgery and radiotherapy, etc., if they are treated with the present protocol as the first therapy.

摘要

5例晚期神经母细胞瘤患者采用泽口组使用的厚生省方案进行治疗。该方案由环磷酰胺(CPM)、长春新碱(VCR)、4'-O-四氢吡喃阿霉素(THP-ADM)和顺铂(CDDP)组成。2例将该方案作为首次治疗的患者获得部分缓解。2例在使用该方案治疗前已获得完全缓解的患者在治疗后仍保持完全缓解。1例在使用该方案治疗前对先前给予的治疗反应不佳的患者对该方案的反应也较差。该方案最显著的副作用是骨髓抑制,其严重程度与THP-ADM的剂量密切相关。对肝脏、肾脏和心脏的损害不太明显。我们主张,如果将目前的方案作为首次治疗,晚期神经母细胞瘤患者借助手术和放疗等手段可获得完全缓解。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验